KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Net Cash Flow (2017 - 2025)

Johnson & Johnson (JNJ) has disclosed Net Cash Flow for 17 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 66.34% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.6 billion through Dec 2025, down 281.34% year-over-year, with the annual reading at -$4.6 billion for FY2025, 281.34% down from the prior year.
  • Net Cash Flow hit $1.5 billion in Q4 2025 for Johnson & Johnson, up from -$300.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $14.3 billion in Q1 2025 to a low of -$20.1 billion in Q2 2025.
  • Historically, Net Cash Flow has averaged -$195.0 million across 5 years, with a median of -$405.0 million in 2024.
  • Biggest five-year swings in Net Cash Flow: surged 414.6% in 2023 and later tumbled 3831.57% in 2025.
  • Year by year, Net Cash Flow stood at $3.4 billion in 2021, then tumbled by 220.1% to -$4.0 billion in 2022, then surged by 149.65% to $2.0 billion in 2023, then soared by 115.5% to $4.3 billion in 2024, then crashed by 66.34% to $1.5 billion in 2025.
  • Business Quant data shows Net Cash Flow for JNJ at $1.5 billion in Q4 2025, -$300.0 million in Q3 2025, and -$20.1 billion in Q2 2025.